triazoles has been researched along with Erythema in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Lipner, SR; Wang, Y | 1 |
Alzghari, SK; Cable, CT; Herrington, JD; Seago, SE | 1 |
Goto, S; Itoh, H; Nagai, M; Ohmori, K; Osada, H; Sasaki, K; Shimizu, S; Shimoda, M; Shirai, J; Watanabe, M | 1 |
Appenzeller, M; Bigliardi, P; Buclin, T; Grouzmann, E; Pannatier, A | 1 |
Moyal, D | 1 |
Hansen, R; Mendelson, D; Park, A; Racette, AJ; Roenigk, HH | 1 |
Chandler, A; Greene, JN; Houston, SH; Silapunt, S; Sriaroon, C; Vincent, AL | 1 |
Denning, DW; Griffiths, CE | 1 |
Arisu, K; Hayakawa, R; Kaniwa, M; Matsunaga, K; Ogino, Y | 1 |
1 trial(s) available for triazoles and Erythema
Article | Year |
---|---|
Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers.
Topics: Capsaicin; Carbonated Beverages; Cross-Over Studies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Edema; Erythema; Humans; Injections, Intradermal; Male; Pain; Pyrazines; Sitagliptin Phosphate; Skin; Substance P; Triazoles; Vasodilation | 2011 |
8 other study(ies) available for triazoles and Erythema
Article | Year |
---|---|
Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration.
Topics: Administration, Topical; Adverse Drug Reaction Reporting Systems; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Erythema; Humans; Nails; Onychomycosis; Pigmentation; Retrospective Studies; Solutions; Treatment Failure; Triazoles; United States; United States Food and Drug Administration | 2020 |
Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine.
Topics: Cytarabine; Drug Interactions; Erythema; Female; Hand-Foot Syndrome; Humans; Leukemia, Myeloid, Acute; Triazoles; Young Adult | 2017 |
Characterization of platelet-activating factor-induced cutaneous edema and erythema in dogs.
Topics: Animals; Azepines; Dogs; Edema; Erythema; Histamine; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prednisolone; Receptors, G-Protein-Coupled; Skin; Skin Diseases; Triazoles | 2016 |
Prevention of ultraviolet-induced skin pigmentation.
Topics: Adolescent; Adult; Camphanes; Camphor; Drug Synergism; Erythema; Humans; Mesylates; Middle Aged; Radiation Dosage; Skin Pigmentation; Sulfonic Acids; Sunburn; Sunlight; Sunscreening Agents; Time Factors; Triazoles; Ultraviolet Rays | 2004 |
Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl.
Topics: Adolescent; Antifungal Agents; Blister; Cheilitis; Erythema; Female; Humans; Pyrimidines; Sinusitis; Skin Aging; Triazoles; Voriconazole | 2005 |
Successful treatment of subcutaneous Scytalidium hyalinum infection with voriconazole and topical terbinafine in a cardiac transplant patient.
Topics: Administration, Topical; Antifungal Agents; Ascomycota; Erythema; Heart Transplantation; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Postoperative Complications; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Cheilitis; Erythema; Female; Humans; Lung Diseases, Fungal; Lupus Erythematosus, Discoid; Male; Middle Aged; Pyrimidines; Retinoids; Sinusitis; Triazoles; Voriconazole | 2001 |
Tinuvin P in a spandex tape as a cause of clothing dermatitis.
Topics: Chromatography, Gel; Clothing; Dermatitis, Contact; Erythema; Female; Humans; Middle Aged; Polyurethanes; Triazoles | 1992 |